Showing results (1281-1290 of 4,563) with videos related to

Sort By:
Pageof 457
Schizophrenia Bulletin|January 1, 1980
Demographic, biologic, and other variables affecting monoamine oxidase activityD S Robinson, A Nies
Schizophrenia Bulletin|January 1, 1980
Metabolic factors affecting monoamine oxidase activityJ L Sullivan, C E Coffey, P D Sullivan, et al.
Schizophrenia Bulletin|January 1, 1978
The diagnostic ambiguity of postpsychotic depressionE Goplerud, R A Depue
Schizophrenia Bulletin|January 1, 1978
Social networks, the family, and the schizophrenic patient: introduction to the issueC C Beels
Schizophrenia Bulletin|May 17, 2020
Antipsychotic Dose in Acute Schizophrenia: A Meta-analysisHiroyoshi Takeuchi, Nicole E MacKenzie, Dominic Samaroo, et al.
Schizophrenia Bulletin|June 8, 2020
The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by SchizophreniaMartina Ulivieri, Joanna Monika Wierońska, Luana Lionetto, et al.
Schizophrenia Bulletin|September 18, 2021
Sleep Disturbance in Individuals at Clinical High Risk for PsychosisNina Zaks, Tjasa Velikonja, Muhammad A Parvaz, et al.
Schizophrenia Bulletin|August 8, 2022
Cerebrospinal Fluid and Blood Biomarkers of Neuroinflammation and Blood-Brain Barrier in Psychotic Disorders and Individually Matched Healthy ControlsRose Jeppesen, Sonja Orlovska-Waast, Nina Vindegaard Sørensen, et al.
Schizophrenia Bulletin|September 15, 2021
Cerebello-Thalamo-Cortical Hyperconnectivity Classifies Patients and Predicts Long-Term Treatment Outcome in First-Episode SchizophreniaHengyi Cao, Xia Wei, Na Hu, et al.
Schizophrenia Bulletin|September 4, 2021
Cerebrospinal Fluid Pathologies in Schizophrenia-Spectrum Disorder-A Retrospective Chart ReviewMattia Campana, Johanna Strauß, Susanne Münz, et al.
Pageof 457